Senior insider sale
Chief Medical Officer at PYXIS ONCOLOGY, INC. — senior position signals high conviction
$463.6K
166.66K shares
What this filing means
FEINGOLD JAY plans to sell 166.66K shares of PYXIS ONCOLOGY, INC. valued at approximately $463.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/31/2023ACC: 0001959173-23-002717
Officer· Chief Medical Officer
Since Oct 2021
166.66K
Shares to sell
$463.6K
Approx. market value
25K
Acquired (3 months)
1
Planned
6 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
4/13/2023
25KTotal acquired25K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/13/2023 | Restricted Stock Vesting Compensation | 25K | — |
| Total | 25K | ||
Planned & Completed Dispositions7
Completed
—Completed
Units to sell
23.02K
Market value
$56.0K
7/27/2023
—Completed
Units to sell
27.36K
Market value
$71.4K
7/21/2023
—Completed
Units to sell
30K
Market value
$83.1K
7/11/2023
—Completed
Units to sell
234.00
Market value
$694.63
6/16/2023
—Completed
Units to sell
23.64K
Market value
$71.1K
6/8/2023
—Completed
Units to sell
37.40K
Market value
$116.7K
6/7/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
25K
Market value
$64.6K
7/31/2023
Total
Units
166.66K
Value
$463.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/27/2023 | 23.02K | $56.0K | — | Completed |
7/21/2023 | 27.36K | $71.4K | — | Completed |
7/11/2023 | 30K | $83.1K | — | Completed |
6/16/2023 | 234.00 | $694.63 | — | Completed |
6/8/2023 | 23.64K | $71.1K | — | Completed |
6/7/2023 | 37.40K | $116.7K | — | Completed |
| Planned — Approximate Date | ||||
7/31/2023 | 25K | $64.6K | NASDAQ | Planned |
| Total | 166.66K | $463.6K | ||